Core Insights - Yuan Tian Biotechnology (Tianjin) Co., Ltd. has recently secured strategic investment from Toyota Tsusho (Shanghai) Co., Ltd., marking a continuation of capital activities following an investment from Tianchuang Capital in September, with total financing amounting to several tens of millions [1][4] - The collaboration will focus on the development of downstream application products in various fields, including textile yarns, industrial yarns, food packaging, and engineering plastics, leveraging Toyota Tsusho's advantages in the automotive supply chain and its established presence in the Japanese market [1][5] Company Overview - Yuan Tian Biotechnology specializes in the industrialization and commercialization of waste PET enzymatic recycling, having developed an efficient PET degrading enzyme that can decompose various waste PET materials into rPTA and rMEG monomers under normal temperature and pressure, enabling the recycling and infinite reuse of PET [1][4] - The company is expanding its recycling capabilities from PET to PA6 (polyamide 6), with the PA6 biological recycling process now capable of operating as a standalone line [1] Production and Technology - Yuan Tian Biotechnology is continuously iterating its production line processes to enhance product quality and reduce costs, with the Rb-PET product showing superior performance compared to virgin PET in several metrics [2] - The company's enzymatic recycling PTA project has been established in Tianjin Economic Development Zone, with a total investment of approximately 150 million yuan, designed for a scale of 5,000 tons, expected to commence production next year [4] Market Expansion - The company is actively pursuing partnerships with brand clients in the textile and daily chemical sectors, aiming to penetrate the automotive supply chain through its collaboration with Toyota Tsusho and expand into the Japanese market [4][5] - The automotive industry is experiencing explosive growth in demand for recycled materials, driven by regulatory pressures and the industry's need for environmentally friendly materials [5] Investment Perspective - Toyota Tsusho is committed to promoting and applying sustainable materials globally, recognizing the broad market potential of Yuan Tian Biotechnology's enzymatic recycling technology and products [6]

Core Viewpoint - The signing of the investment cooperation memorandum between Yuan Tian Biotechnology (Tianjin) Co., Ltd. and the Tianjin Economic and Technological Development Zone marks the official launch of the world's first 5,000-ton bio-enzyme method for recycling purified terephthalic acid (rPTA) project in Tianjin [1] Investment and Project Details - The total investment for the project is approximately 150 million yuan, with production expected to commence by mid-2026 [1] - The project aims to process about 10,000 tons of waste textiles annually [1] Technology and Production Efficiency - The bio-enzyme recycling technology offers better raw material compatibility, supporting both post-consumer recycled (PIR) textiles and post-consumer recycled (PCR) blends [1] - The PET degrading enzyme developed by Yuan Tian Biotechnology has increased enzyme activity by 2,000 times, achieving a significant efficiency leap with an 8-hour degradation time [1] Product Quality and Cost Efficiency - The quality of the products (rPTA and rEG) is comparable to virgin materials, achieving "zero perceptible difference" from petroleum-based materials [1] - The bio-enzyme method utilizes an all-aqueous system, operates at room temperature and pressure, and does not require organic solvents, resulting in lower energy consumption and significantly reduced costs [1] Environmental Impact and Future Plans - Once the 5,000-ton rPTA production line is established, the company will focus on recycling and regenerating post-consumer waste textiles as a key raw material source, creating a closed-loop industry chain from "waste textiles to rPTA/rEG to rbPET to recycled fibers" [1] - The company plans to further develop a 100,000-ton/year bio-enzyme method rPTA production line in the future [1]

近日，源天生物完成数千万元pre-A++轮融资。 本轮融资由天创资本独家投资，本轮资金将主要用于5000吨产线全面建设与10万吨产线规划布局，加速实现生物酶法再生材料的规模化量产，为公司下一 步发展奠定坚实基础。 PART.01 资本持续加持 一年内完成三轮融资彰显市场信心 作为国内首家实现生物法再生技术商业化落地的公司，本次天创资本的投资加持，不仅体现了资本市场对源天生物的高度关注，更让生物酶法再生技术的 产业化进程全面加速。 天创资本程伟表示：rbPET市场空间巨大且刚需明显，源天生物的生物酶法路线在兼具原料范围广、工艺路线优、回收率高、产品性能优等特点的同时极 具成本优势。天创资本长期布局新材料赛道，希望通过本次投资加速企业产能布局及新品研发，助力源天生物成为全球绿色循环材料领域的龙头企业。 尼龙循环新时代 基于PET酶法再生的成功经验，源天生物正构建「塑料再生技术矩阵」，拓展从PET到PA6的多塑料再生体系。 近期，源天生物在聚酰胺6（PA6）生物法回收上的取得重要进展。通过生物酶法为PA6材料的循环利用提供了创新解决方案，其温和的反应条件和环保特 性，为纺织、汽车、电子等行业的PA6材料可持续利用提 ...